Personalized Outreach for Equitable Treatment in Rheumatology
NCT ID: NCT07022756
Last Updated: 2025-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
20 participants
INTERVENTIONAL
2025-07-02
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer are:
* Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic?
* Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic?
The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach.
Participants will:
* Undergo randomization to receive honoraria or honoraria and outreach services together
* Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals
* Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outpatient Follow-up on Demand in Rheumatoid Arthritis
NCT04476875
Interprofessional Care Models Using Videoconferencing for Patients With Inflammatory Arthritis
NCT02371915
Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
NCT07034196
Self-assessment Triage in Inflammatory Arthritis
NCT04956380
Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis
NCT02720874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will aim to enroll 20 participants between July 2025 and October 2025. Participants will be randomized to either honorarium with outreach or honorarium alone arms in a 1:1 fashion, stratified by housing status (unhoused and emergency sheltered in one strata, provisionally accommodated and stably housed in the second strata).
All enrolled participants will receive a $20 honorarium for each in-person assessment with completed monitoring bloodwork as requested by the treating rheumatologist. The program will last 6 months for each patient from time of enrolment, or until a patient chooses to leave the program, whichever is sooner. At baseline, participants will complete two surveys: one on their general health status, and one specific to their rheumatic disease. At the 3-month and 6-month visits, these surveys will be repeated, and a semi-structured interview will be completed to obtain feedback on the pilot program.
The outcomes of this study will inform how rheumatologists can better care for those who live with inflammatory arthritis and are also marginalized by extreme poverty and/or housing instability. The investigators plan on disseminating and discussing results with our participants, community members, inner city physicians, and rheumatologists. If there are specific positive themes or outcomes from the study, the investigators will advocate for additional resources to permit long-term implementation and further study to confirm results, make further improvements to our program, and improve generalizability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Honoraria Only
Participants in this arm of the study will only receive honoraria and not outreach
Honoraria
A $20 honorarium for each appointment attended with completed bloodwork if requested.
Honoraria and Outreach
Participants in this arm of the study will receive both honoraria and outreach services
Honoraria
A $20 honorarium for each appointment attended with completed bloodwork if requested.
Outreach
A personalized outreach service specific for rheumatic disease.
Historical Control
The attendance rate to follow-up appointments among all patients with inflammatory arthritis due to a rheumatic disease at the Pender Rheumatology Clinic from Jan 2023 to Jun 2025.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Honoraria
A $20 honorarium for each appointment attended with completed bloodwork if requested.
Outreach
A personalized outreach service specific for rheumatic disease.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be attached to one of the Vancouver Coastal Health Community Health Centres for primary care
* Be willing to attend in-person appointments at Pender Community Health Centre
* Be at least 18 years of age and capable of consenting to participation
* Be able to receive medical care in English.
Exclusion Criteria
* Have no reasonably reliable method of contact (phone, email, social media, etc.)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mary Pack Arthritis Center
UNKNOWN
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alec Yu
Lead Investigator - Personalized Outreach for Equitable Treatment in Rheumatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brent R Ohata, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pender Community Health Centre
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H24-03984
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.